Public Profile

Komtur Pharmaceuticals GmbH

Komtur Pharmaceuticals GmbH, a prominent player in the pharmaceutical industry, is headquartered in Germany and operates extensively across Europe. Founded in 1992, the company has established itself as a leader in the development and distribution of high-quality pharmaceutical products, particularly in the areas of generics and specialty medications. With a commitment to innovation, Komtur Pharmaceuticals offers a diverse portfolio that includes prescription medications and over-the-counter products, distinguished by their rigorous quality standards and efficacy. The company has achieved significant milestones, including strategic partnerships and expansions that have solidified its market position. Recognised for its dedication to patient care and safety, Komtur Pharmaceuticals continues to make strides in the healthcare sector, ensuring access to essential medications while maintaining a strong focus on research and development.

DitchCarbon Score

How does Komtur Pharmaceuticals GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

0

Industry Average

Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

0

Industry Benchmark

Komtur Pharmaceuticals GmbH's score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Komtur Pharmaceuticals GmbH's reported carbon emissions

Komtur Pharmaceuticals GmbH, headquartered in Germany, currently does not have available data on its carbon emissions, as no specific emissions figures have been reported. Consequently, there are no defined reduction targets or climate commitments outlined by the company at this time. In the context of the pharmaceutical industry, companies are increasingly focusing on sustainability and reducing their carbon footprints, often setting ambitious targets aligned with global climate initiatives. However, without specific data or commitments from Komtur Pharmaceuticals, it is unclear how they are addressing climate change and carbon emissions.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Komtur Pharmaceuticals GmbH's primary industry is , which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Komtur Pharmaceuticals GmbH is headquartered in DE, which has a rank of medium, indicating medium grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Komtur Pharmaceuticals GmbH is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Clinigen

GB
Medical, precision and optical instruments, watches and clocks (33)
Updated 6 days ago

Abacus Medicine

DK
Medical, precision and optical instruments, watches and clocks (33)
Updated 6 days ago

West Lodge Capital Limited

GB
Real estate services (70)
Updated 6 days ago

Smartway Pharmaceuticals Limited

GB
Chemicals nec
Updated 6 days ago

Specific Pharma A/s

DK
Chemicals nec
Updated 30 days ago
DitchCarbon Score

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers